Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Palladium-103 Seed Implant and Single Daily Dosing of Uroxatral Vs. Twice Daily Dosing of Flomax- A 3 Month Retrospective Efficacy Analysis

This study has been completed.
Sponsor:
Collaborator:
Sanofi
Information provided by:
Dattoli Cancer Center and Brachytherapy Research Institute
ClinicalTrials.gov Identifier:
NCT00264017
First received: December 6, 2005
Last updated: NA
Last verified: November 2005
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: November 2005
  Estimated Primary Completion Date: No date given